BSE - Delayed Quote INR

Morepen Laboratories Limited (MOREPENLAB.BO)

Compare
68.22
-2.66
(-3.75%)
At close: January 10 at 3:58:45 PM GMT+5:30

Key Executives

Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in INR.
NameTitlePayExercisedYear Born
Mr. Sushil Suri B.Sc., F.C.A., FCA Chairman & MD -- -- 1964
Mr. Sanjay Suri Whole-Time Director -- -- 1968
Mr. Ajay Kumar Sharma Chief Financial Officer 9.8M -- 1967
Mr. Bhola Prasad General Manager of Process Engineering & Technology Transfer -- -- --
Ms. Sunita Suri Manager of Administration -- -- 1994
Mr. Vipul Kumar Srivastava Company Secretary & Compliance Officer 1.84M -- 1985
Mr. Vikas Sharma Functional Head of Talent Acquisition & HRBP -- -- --
Ms. Amita Sharma Chief Operating Officer of API -- -- 1966
Mr. Anubhav Suri Head of Medipath Division -- -- 1987
Mr. Kushal Suri Head of International Business Development -- -- 1989

Morepen Laboratories Limited

Tower C, DLF Cyber Park
2nd Floor Udyog Vihar-III, Sector-20
Gurugram, 122016
India
91 12 4489 2000 https://www.morepen.com
Sector: 
Healthcare
Full Time Employees: 
2,152

Description

Morepen Laboratories Limited develops, manufactures, markets, and sells active pharmaceutical ingredients (APIs), formulations, and home health products in India, the United States, and internationally. The company offers APIs for anti-histaminic, anti-asthmatic, anti-lipemic, anti-hypertensive, anti-diabetic, anti-coagulant, anti-ulcerative, and anti-depressant drugs; and home diagnostic products, such as air purifiers, sphygmomanometer, blood glucose test strips, blood pressure monitors, breathe free vaporizers, stethoscopes, digital thermometers, blood glucose monitors, nebulizers, heat belts, and pulse oximeters. It also provides OTC and healthcare products, including fever X for fever; Pain X for pain; Fiber-X for constipation; sat isabgol; Acidity X for acidity; Burnol, first degree/minor burns cream; and formulations for nutrition and probiotics, gastroenterology, antibiotics, gynecology, anti-allergic, and central nervous system, as well as cardiology, diabetology, and nutraceuticals. The company offers over the counter products under the Dr. Morepen brand. Morepen Laboratories Limited was incorporated in 1984 and is based in Gurugram, India.

Corporate Governance

Morepen Laboratories Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

January 29, 2025 at 10:59 AM UTC - February 3, 2025 at 12:00 PM UTC

Morepen Laboratories Limited Earnings Date

Recent Events

September 18, 2002 at 12:00 AM UTC

Ex-Dividend Date

Related Tickers